Pathogenesis and treatment of immune-mediated neuropathies
- PMID: 21179533
- PMCID: PMC3002632
- DOI: 10.1177/1756285609104792
Pathogenesis and treatment of immune-mediated neuropathies
Abstract
Immune-mediated neuropathies represent a heterogeneous spectrum of peripheral nerve disorders that can be classified according to time course, predominant involvement of motor/sensory fibers, distribution of deficits and paraclinical parameters such as electrophysiology and serum antibodies. In the last few years, significant advances have been achieved in elucidating underlying pathomechanisms, which made it possible to identify potential therapeutic targets. In this review, we discuss the latest development in pathogenesis and treatment of immune-mediated neuropathies.
Keywords: Guíllan-Barré syndrome; cidp; immune neuropathies; paraproteinemic neuropathies; treatments.
References
-
- Allen D., Lunn M.P., Niermeijer J., Nobile-Orazio E. (2007) Treatment for IgG and IgA paraproteinaemic neuropathy. Cochrane Database Syst Rev CD005376 - PubMed
-
- Andersen S.M., Ling C.C., Zhang P., Townson K., Willison H.J., Bundle D.R. (2004) Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. Org Biomol Chem 2: 1199–1212 - PubMed
-
- Asbury A.K., Arnason B.G., Adams R.D. (1969) The inflammatory lesion in idiopathic polyneuritis. Medicine 4: 173–215 - PubMed
-
- Auer R., Bell R., Lee M. (1989) Neuropathy with onion bulb formations and pure motor manifestations. Can J Neurol Sci 16: 194–197 - PubMed
-
- Axelson H., Oberg G., Askmark H. (2008a) No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy. Acta Neurol Scand 117: 432–434 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources